Insider Transactions in Q4 2021 at Catalent, Inc. (CTLT)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 30
2021
|
Peter Zippelius Director |
SELL
Open market or private sale
|
Indirect |
3,000,000
-38.35%
|
$387,000,000
$129.3 P/Share
|
|
Nov 29
2021
|
J Martin Carroll |
BUY
Other acquisition or disposition
|
Indirect |
3,136
+21.19%
|
$420,224
$134.12 P/Share
|
|
Nov 29
2021
|
J Martin Carroll |
SELL
Other acquisition or disposition
|
Indirect |
3,136
-100.0%
|
$420,224
$134.12 P/Share
|
|
Nov 29
2021
|
J Martin Carroll |
BUY
Bona fide gift
|
Indirect |
3,136
+50.0%
|
-
|
|
Nov 29
2021
|
J Martin Carroll |
SELL
Bona fide gift
|
Direct |
3,136
-16.07%
|
-
|
|
Nov 23
2021
|
Gregory T Lucier |
SELL
Open market or private sale
|
Indirect |
5,068
-76.32%
|
$643,636
$127.37 P/Share
|
|
Nov 18
2021
|
Peter Zippelius Director |
BUY
Conversion of derivative security
|
Indirect |
7,822,946
+50.0%
|
$383,324,354
$49.54 P/Share
|
|
Nov 01
2021
|
Jonathan Arnold SVP, CCO & Div. Head BioP Del. |
SELL
Open market or private sale
|
Direct |
10,672
-20.27%
|
$1,494,080
$140.02 P/Share
|
|
Nov 01
2021
|
Jonathan Arnold SVP, CCO & Div. Head BioP Del. |
BUY
Exercise of conversion of derivative security
|
Direct |
7,559
+3.65%
|
$332,596
$44.27 P/Share
|
|
Oct 28
2021
|
Madhavan Balachandran Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,402
+7.92%
|
-
|
|
Oct 28
2021
|
Michael J Barber |
BUY
Grant, award, or other acquisition
|
Direct |
1,402
+38.42%
|
-
|
|
Oct 28
2021
|
J Martin Carroll |
BUY
Grant, award, or other acquisition
|
Direct |
1,402
+6.7%
|
-
|
|
Oct 28
2021
|
Rolf A Classon |
BUY
Grant, award, or other acquisition
|
Direct |
1,402
+4.18%
|
-
|
|
Oct 28
2021
|
Rosemary A Crane Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,402
+9.92%
|
-
|
|
Oct 28
2021
|
John J Greisch Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
1,402
+9.92%
|
-
|
|
Oct 28
2021
|
Christa Kreuzburg Director |
SELL
Payment of exercise price or tax liability
|
Direct |
638
-6.4%
|
$86,130
$135.5 P/Share
|
|
Oct 28
2021
|
Christa Kreuzburg Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,402
+12.33%
|
-
|
|
Oct 28
2021
|
Gregory T Lucier |
BUY
Grant, award, or other acquisition
|
Direct |
1,402
+6.23%
|
-
|
|
Oct 28
2021
|
Donald E Morel Jr |
BUY
Grant, award, or other acquisition
|
Direct |
1,402
+2.52%
|
-
|
|
Oct 28
2021
|
Jack L Stahl |
BUY
Grant, award, or other acquisition
|
Direct |
1,402
+4.18%
|
-
|
|
Oct 28
2021
|
Peter Zippelius Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,402
+15.19%
|
-
|
|
Oct 20
2021
|
Thomas P Castellano SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,307
-13.03%
|
$309,138
$134.0 P/Share
|
|
Oct 14
2021
|
Jonathan Arnold SVP, CCO & Div. Head BioP Del. |
SELL
Open market or private sale
|
Direct |
1,661
-3.55%
|
$214,269
$129.41 P/Share
|
|
Oct 04
2021
|
Steven L Fasman EVP & Chief Admin Officer |
SELL
Open market or private sale
|
Direct |
34,714
-10.88%
|
$4,478,106
$129.79 P/Share
|
|
Oct 04
2021
|
Steven L Fasman EVP & Chief Admin Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,259
+4.78%
|
$949,245
$55.74 P/Share
|
|
Oct 04
2021
|
Kay A Schmidt SVP, Enterprise Functions |
SELL
Open market or private sale
|
Direct |
2,191
-13.72%
|
$287,021
$131.25 P/Share
|
|
Oct 01
2021
|
John R Chiminski Executive Chair |
SELL
Open market or private sale
|
Direct |
152,637
-9.39%
|
$19,842,810
$130.19 P/Share
|
|
Oct 01
2021
|
John R Chiminski Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
75,838
+8.55%
|
$2,881,844
$38.27 P/Share
|
|
Oct 01
2021
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
SELL
Open market or private sale
|
Direct |
2,055
-3.67%
|
$267,150
$130.19 P/Share
|
|
Oct 01
2021
|
Ricardo Pravda Chief Transformation Officer |
SELL
Open market or private sale
|
Direct |
4,906
-29.46%
|
$647,592
$132.68 P/Share
|
|
Oct 01
2021
|
Ricardo Pravda Chief Transformation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,818
+10.43%
|
$271,078
$71.52 P/Share
|